The current price of 1548.HK is HK$33.68 — it has decreased by 0.94% since the previous close. Data as of Nov 5, 2026.
1548.HK is down 5.66% over the past week, down 26.21% over the past month and up 107.13% over the past year. The price is above its 200-day moving average of HK$19.87.
Of the 7 analysts covering Genscript Biotech Corporation, 2 rate it a strong buy and 5 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Genscript Biotech Corporation has a market capitalization of HK$75.75B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Genscript Biotech Corporation posted a loss of HK$0.4644 per share. Upcoming reports are listed in the earnings calendar.
Genscript Biotech Corporation reported revenue of HK$3.17B in its most recent quarter, which has decreased by 22.16% compared with the same quarter a year earlier. Analysts had expected HK$3.01B.
Genscript Biotech Corporation has not paid any dividends over the past year.
In the latest trading session 1548.HK moved between HK$32.48 and HK$34.24, a range of 5.23% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Genscript Biotech Corporation shows a sell rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Genscript Biotech Corporation is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 1548.HK has traded between HK$10.36 and HK$49.46. The current price is 31.90% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.